AIDS (London, England) · 2026
Changes in cardiovascular and metabolic risk scores after switching to DOR/3TC/TDF, DTG/3TC or BIC/FTC/TAF: results from a multicenter Italian cohort.
СтатьяМногоцентровое исследованиеНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ciccullo Arturo, Iannone Valentina, Giacomelli Andrea, Baldin Gianmaria, Lagi Filippo, Sambo Margherita, Oreni Letizia, Fabbiani Massimiliano, Borghetti Alberto, Papalini Chiara, Madeddu Giordano, Mussini Cristina, Antinori Spinello, Di Giambenedetto Simona
Аннотация
OBJECTIVE: To assess changes of cardiovascular risk scores and metabolic scores after switching to DOR/3TC/TDF (DOR group), DTG/3TC (DTG group) or BIC/FTC/TAF (BIC group).
METHODS: We analyzed data from 1069 virologically suppressed people with HIV (PWH), collecting clinical history and laboratory parameters at baseline (date of switch) and 48 weeks of follow-up. In eligible PWH, we calculated body mass index (BMI), SCORE-2 for cardiovascular risk assessment and the metabolic score for insulin resistance (METS-IR) at both timepoints and performed linear mixed model for repeated measures to measure changes in parameters, while using linear regression analyses to search for predictors of change.
RESULTS: After 48 weeks, we observed significant changes in median SCORE-2 in all groups: there were increases of +0.12 in the DTG group ( P = 0.021) and +0.30 in the BIC group (<0.001), while we observed a decrease of -0.35 in the DOR group ( P < 0.001). In our regression analyses, taking DOR/3TC/TDF was a predictor of reduction of SCORE-2 compared with both DTG ( P < 0.001) and BIC ( P < 0.001).Regarding BMI, after 48 weeks we observed a median increase of +0.2 in BIC ( P < 0.001), no changes in the DTG group and a median decrease of -0.04 in the DOR group ( P < 0.001).Regarding METS-IR, after 48 weeks we observed a significant decrease in the DOR group (-0.9, P = 0.024), while there were no significant changes with DTG and an increase of +0.3 with BIC ( P = 0.013).
CONCLUSION: We found that switching to DOR/3TC/TDF was associated with more favorable changes in SCORE-2 and METS-IR compared to DTG/3TC and BIC/FTC/TAF.
METHODS: We analyzed data from 1069 virologically suppressed people with HIV (PWH), collecting clinical history and laboratory parameters at baseline (date of switch) and 48 weeks of follow-up. In eligible PWH, we calculated body mass index (BMI), SCORE-2 for cardiovascular risk assessment and the metabolic score for insulin resistance (METS-IR) at both timepoints and performed linear mixed model for repeated measures to measure changes in parameters, while using linear regression analyses to search for predictors of change.
RESULTS: After 48 weeks, we observed significant changes in median SCORE-2 in all groups: there were increases of +0.12 in the DTG group ( P = 0.021) and +0.30 in the BIC group (<0.001), while we observed a decrease of -0.35 in the DOR group ( P < 0.001). In our regression analyses, taking DOR/3TC/TDF was a predictor of reduction of SCORE-2 compared with both DTG ( P < 0.001) and BIC ( P < 0.001).Regarding BMI, after 48 weeks we observed a median increase of +0.2 in BIC ( P < 0.001), no changes in the DTG group and a median decrease of -0.04 in the DOR group ( P < 0.001).Regarding METS-IR, after 48 weeks we observed a significant decrease in the DOR group (-0.9, P = 0.024), while there were no significant changes with DTG and an increase of +0.3 with BIC ( P = 0.013).
CONCLUSION: We found that switching to DOR/3TC/TDF was associated with more favorable changes in SCORE-2 and METS-IR compared to DTG/3TC and BIC/FTC/TAF.